Identification of novel microRNA signatures linked to acquired aplastic anemia

Haematologica

Volumn 100, Issue 12, 2015, Pages 1534-1545

  Hosokawa, Kohei ^a   Muranski, Pawel ^a   Feng, Xingmin ^a   Keyvanfar, Keyvan ^a   Townsley, Danielle M ^a   Dumitriu, Bogdan ^a   Chen, Jichun ^a   Kajigaya, Sachiko ^a   Taylor, James G ^a   Hourigan, Christopher S ^a   Barrett, A John ^a   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MICRORNA; MICRORNA 126 3P; MICRORNA 145 5P; MICRORNA 199A 5P; MICRORNA 223 3P; UNCLASSIFIED DRUG;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SCHOOL CHILD; UPREGULATION; YOUNG ADULT; ADOLESCENT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PATHOLOGY;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MICRORNAS; MIDDLE AGED;

EID: 84948962426     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2015.126128     Document Type: Article

References (56)

1. Young NS, Bacigalupo A, Marsh JC. Aplastic anemia: pathophysiology and treatment. Biol Blood Marrow Transplant. 2010;16(1): 119-125.
2. Sloand E, Kim S, Maciejewski JP, Tisdale J, Follmann D, Young NS. Intracellular interferon- gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood. 2002;100(4):1185-1191.
3. Risitano AM, Kook H, Zeng W, Chen G, Young NS, Maciejewski JP. Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry. Blood. 2002;100(1):178-183.
4. Dufour C, Capasso M, Svahn J, et al. Homozygosis for (12) CA repeats in the first intron of the human IFN-gamma gene is significantly associated with the risk of aplastic anaemia in Caucasian population. Br J Haematol. 2004;126(5):682-685.
5. Solomou EE, Keyvanfar K, Young NS. T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood. 2006;107(10):3983-3991.
6. + T cells from the bone marrow of acquired aplastic anemia patients. Exp Hematol. 2004;32(9):806-814.
7. Eulalio A, Huntzinger E, Izaurralde E. Getting to the root of RNA-mediated gene silencing. Cell. 2008;132(1):9-14.
8. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell. 2003;115(2):199-208.
9. Meister G, Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature. 2004;431(7006):343-349.
10. Grimson A, Farh KK, Johnston WK, Garrett- Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007;27 (1):91-105.
11. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34(Database issue): 140-144.
12. Marcucci G, Mrozek K, Radmacher MD, Garzon R, Bloomfield CD. The prognostic and functional role of microrRNAs in acute myeloid leukemia. Blood. 2011;117(4):1121-1129.
13. Quiat D, Olson EN. MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. J Clin Invest. 2013;123 (1):11-18.
14. Hebert SS, De Strooper B. Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci. 2009;32(4): 199-206.
15. Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell. 2009;136(1):26-36.
16. Nakasa T, Miyaki S, Okubo A, et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2008;58(5):1284-1292.
17. Du C, Liu C, Kang J, et al. MicroRNA miR- 326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol. 2009;10(12):1252-1259.
18. Iborra M, Bernuzzi F, Invernizzi P, Danese S. MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response. Autoimmun Rev. 2012; 11(5):305-314.
19. Li YT, Chen SY, Wang CR, et al. Brief report: amelioration of collagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA-223. Arthritis Rheum. 2012;64 (10):3240-3245.
20. Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976;48(1):63-70.
21. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genomewide expression patterns. Proc Natl Acad Sci USA. 1998;95(25):14863-14868.
22. Vlachos IS, Kostoulas N, Vergoulis T, et al. DIANA miRpath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res. 2012;40(Web Server issue):W498-504.
23. Ranganathan P, Heaphy CE, Costinean S, et al. Regulation of acute graft-versus-host disease by microRNA-155. Blood. 2012;119 (20):4786-4797.
24. Sun Y, Tawara I, Zhao M, et al. Allogeneic T cell responses are regulated by a specific miRNA-mRNA network. J Clin Invest. 2013;123 (11):4739-4754.
25. + T cells by the microRNA miR-125b. Nat Immunol. 2011;12(8): 796-803.
26. Mestdagh P, Hartmann N, Baeriswyl L, et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods. 2014;11(8):809-815.
27. + T cells are increased in patients with severe aplastic anemia. Mol Med Rep. 2014;10(3): 1252-1258.
28. Brand A. Immunological aspects of blood transfusions. Transpl Immunol. 2002;10(2-3):183-190.
29. Afable MG, Wlodarski M, Makishima H, et al. SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes. Blood. 2011;117(25):6876-6884.
30. Rhyasen GW, Starczynowski DT. Deregulation of microRNAs in myelodysplastic syndrome. Leukemia. 2012;26(1):13-22.
31. Starczynowski DT, Kuchenbauer F, Argiropoulos B, et al. Identification of miR-145 and miR-146a as mediators of the 5qsyndrome phenotype. Nat Med. 2010;16(1): 49-58.
32. + cells of 5q- syndrome. J Hematol Oncol. 2011;4:1.
33. Chen SY, Wang Y, Telen MJ, Chi JT. The genomic analysis of erythrocyte microRNA expression in sickle cell diseases. PLoS One. 2008;3(6): 2360.
34. Jain S, Kapetanaki MG, Raghavachari N, et al. Expression of regulatory platelet microRNAs in patients with sickle cell disease. PLoS One. 2013;8(4):e60932.
35. Sachdeva M, Zhu S, Wu F, et al. P53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA. 2009;106(9):3207-3212.
36. Wang R, Dillon CP, Shi LZ, et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 2011;35(6):871-882.
37. + cell populations based on global gene and microRNA expression signatures. Blood. 2009;114(12):2530-2541.
38. + cells. Dev Cell. 2012;23(1):45-57.
39. Lechman ER, Gentner B, van Galen P, et al. Attenuation of miR-126 activity expands HSC in vivo without exhaustion. Cell Stem Cell. 2012;11(6):799-811.
40. Kim EH, Suresh M. Role of PI3K/Akt signaling in memory CD8 T cell differentiation. Front Immunol. 2013;4:20.
41. +) regulatory T cells through PI3K/AKT pathway. J Cell Mol Med. 2013;17(2):252-264.
42. +) regulatory T cells in acquired aplastic anemia. Blood. 2012;120 (8):1624-1632.
43. Felli N, Pedini F, Romania P, et al. MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis. Haematologica.2009;94(4):479-486.
44. O’Connell RM, Rao DS, Baltimore D. Microrna regulation of inflammatory responses. Annu Rev Immunol. 2012;(30): 295-312.
45. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappab-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA. 2006; 103(33):12481-12486.
46. Wang J, Zheng S, Xin N, et al. Identification of novel microRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated mir-145 promotes pathogenetic Th17 cell response. J Neuroimmune Pharmacol. 2013;8(5):1287-1302.
47. Lu MC, Lai NS, Chen HC, et al. Decreased microRNA(mir)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis. Clin Exp Immunol. 2013;171(1):91-99.
48. Lu MC, Yu CL, Chen HC, Yu HC, Huang HB, Lai NS. Increased miR-223 expression in T cells from patients with rheumatoid arthritis leads to decreased insulin-like growth factor-1-mediated interleukin-10 production. Clin Exp Immunol. 2014;177(3): 641-651
49. Di Lisio L, Sanchez-Beato M, Gomez-Lopez G, et al. MicroRNA signatures in B-cell lymphomas. Blood Cancer J. 2012;2(2):e57.
50. Caramuta S, Lee L, Ozata DM, et al. Role of microRNAs and microrna machinery in the pathogenesis of diffuse large B-cell lymphoma. Blood Cancer J. 2013;3: 152.
51. Hirano N, Butler MO, Von Bergwelt-Baildon MS, et al. Autoantibodies frequently detected in patients with aplastic anemia. Blood. 2003;102(13):4567-4575.
52. Takamatsu H, Feng X, Chuhjo T, et al. Specific antibodies to moesin, a membranecytoskeleton linker protein, are frequently detected in patients with acquired aplastic anemia. Blood. 2007;109(6):2514-2520.
53. Stagakis E, Bertsias G, Verginis P, et al. Identification of novel microrna signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis. 2011;70(8): 1496-1506.
54. Mestdagh P, Van Vlierberghe P, De Weer A, et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 2009;10(6):R64.
55. Gargiulo L, Papaioannou M, Sica M, et al. Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria. Blood. 2013;121(14): 2753-2761.
56. Inaguma Y, Akatsuka Y, Hosokawa K, et al. Induction of HLA-B*40:02-restricted T cells possessing cytotoxic and suppressive functions against haematopoietic progenitor cells from a patient with severe aplastic anaemia. Br J Haematol. 2015 Apr 30. [Epub ahead of print]